


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.27%
+3.92%
+1.72%
ARWR
Arrowhead Pharmaceuticals
$41.50
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Risk Analysis

Investors losing their confidence
Chart
$36.25 (+14.48%)
$20.51 (+102.34%)
$15.62 (+165.69%)
$18.28 (+127.02%)
ARWR has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

ARWR overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow
![]()
ARWR Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ARWR Street Sentiment is unimpressive and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is ARWR current stock price?
What are ARWR stock strengths?
What risks are associated with ARWR stock?
When is ARWR next earnings report?
What is ARWR market cap and volume?
What is ARWR's current Stock IQ?
Should I buy ARWR stock right now?
Is ARWR a Strong Buy right now?
What does a 'Strong Buy' rating mean for ARWR?
What does a 'Strong Sell' rating mean for ARWR?
What factors influence ARWR's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.27%
+3.92%
+1.72%
ARWR
Arrowhead Pharmaceuticals
Current Price
$41.50
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued
Risk Analysis

Investors losing their confidence

Chart
$36.25 (+14.48%)
$20.51 (+102.34%)
$15.62 (+165.69%)
$18.28 (+127.02%)
ARWR Analysts Opinion
ARWR Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors losing their confidence
Future
Future

Earnings are forecast to grow
![]()
ARWR Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
ARWR Street Sentiment is unimpressive and have negative views on the near-term outlook
ARWR has Extreme risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels.
ARWR Latest Analysis
Privium Fund Management Sells Into Strength in Pharma Stock. Key PointsSold 138263 shares of Arrowhead Pharmaceuticals. Estimated transaction value: $3039518
Tue Nov 4, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
ARWR Stock trends
ARWR Stock performance
ARWR Stock analysis
ARWR investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.